Repare Therapeutics Inc (RPTX)
3.24
-0.04
(-1.22%)
USD |
NASDAQ |
Nov 14, 16:00
3.24
0.00 (0.00%)
After-Hours: 20:00
Repare Therapeutics Total Assets (Quarterly): 235.34M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 206.39M |
June 30, 2024 | 235.34M |
March 31, 2024 | 263.08M |
December 31, 2023 | 253.90M |
September 30, 2023 | 286.41M |
June 30, 2023 | 301.59M |
March 31, 2023 | 336.31M |
December 31, 2022 | 364.08M |
September 30, 2022 | 409.16M |
June 30, 2022 | 308.04M |
Date | Value |
---|---|
March 31, 2022 | 337.15M |
December 31, 2021 | 368.72M |
September 30, 2021 | 295.64M |
June 30, 2021 | 320.65M |
March 31, 2021 | 339.07M |
December 31, 2020 | 357.09M |
September 30, 2020 | 370.24M |
June 30, 2020 | 381.73M |
March 31, 2020 | 93.57M |
December 31, 2019 | 102.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
93.57M
Minimum
Mar 2020
409.16M
Maximum
Sep 2022
296.54M
Average
314.35M
Median
Total Assets (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 549.36M |
Edesa Biotech Inc | 5.228M |
Lexaria Bioscience Corp | 10.02M |
InMed Pharmaceuticals Inc | 11.82M |
Xenon Pharmaceuticals Inc | 884.01M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 31.67M |
Shareholders Equity (Quarterly) | 203.68M |
Current Ratio | 7.267 |